Between Scylla and Charybdis: thrombosis in children with hemophilia
Thromboembolism is an infrequent complication in children with hemophilia that has been traditionally associated with the presence of a central venous access device. Novel rebalancing agents have shown promising results as prophylactic therapies to minimize the risk of bleeding but both thromboembol...
Main Authors: | Jad El Maamari, Ali Amid, Marie-Claude Pelland-Marcotte, Soumitra Tole |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-05-01
|
Series: | Frontiers in Pediatrics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fped.2023.1173549/full |
Similar Items
-
Emicizumab Associated Rhabdomyolysis in Hemophilia A
by: Joseph A. Wilson, et al.
Published: (2020-10-01) -
Real‐world use of emicizumab in Chinese children with hemophilia A: Retrospective data from a comprehensive care center
by: Qianqian Mao, et al.
Published: (2024-12-01) -
Challenges in prophylactic therapy with Emicizumab in patients with hemophilia A: Focus on monitoring tests
by: Brinza Melen, et al.
Published: (2024-01-01) -
Management of children with hemophilia A on emicizumab who need surgery
by: Mark Belletrutti, et al.
Published: (2023-04-01) -
Editorial: Modern approaches to hemophilia management in children and adolescents
by: Ali Amid
Published: (2023-09-01)